Clinical Trials Directory

Trials / Completed

CompletedNCT03712683

Thyroxin in Subclinical Hypothyroidism

Prevalence of Subclinical Hypothyroidism in Women With Unexplained Infertility and the Effect of Thyroxin on Pregnancy Rate

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Hawler Medical University · Academic / Other
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Not accepted

Summary

Subclinical hypothyroidism(SCH) is the elevated thyroid stimulating hormone (TSH) with normal free Thyroxine levels and it is a mild or compensated form of primary hypothyroidism. It has been suggested that SCH is more prevalent in infertile women (especially in women with ovulatory disorders.Various rates of SCH was reported in infertile women in different populations

Detailed description

Despite well-established recommendations on screening and treatment of overt hypothyroid in infertile women, there is a controversy regard the treatment of SCH in infertile women . There are few published data on the prevalence of SCH and the outcome of treatment of SCH in infertile women, many were conducted during IVF cycles . Moreover there are inconsistent results in these studies being authors advised to treat SCH before IVF and some other articles find out no any benefit regarding treatment with Thyroxine in SCH

Conditions

Interventions

TypeNameDescription
DRUGThyroxineThyroxine was prescribed with the diagnosis of SCH and continued when pregnancy was confirmed

Timeline

Start date
2016-09-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2018-10-19
Last updated
2018-10-29

Source: ClinicalTrials.gov record NCT03712683. Inclusion in this directory is not an endorsement.

Thyroxin in Subclinical Hypothyroidism (NCT03712683) · Clinical Trials Directory